# \[Possible intervention of glucagon in the genesis of various primary hyperlipemias\].

> PubMed lists PMID 6515072 in Revista clinica espanola as English Abstract, Journal Article, with publication-date metadata of 1984 Aug 15-31 (source-text precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-6515072-glucagon:v1`
- Evidence domain: Literature metadata
- Date in source: 2006-11-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-6515072-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-6515072-glucagon-v1.json
- Content SHA-256: `628588e978fbc437c533638034b1a4cfe9a68171a9ff6916557c16e1ca1b9455`

## Claims and source pins

### Headline

\[Possible intervention of glucagon in the genesis of various primary hyperlipemias\]. ([`pubmed-observation-pmid-6515072-2006-11-15-4be533a80309`](#source-pubmed-observation-pmid-6515072-2006-11-15-4be533a80309))

### Summary

PubMed lists PMID 6515072 in Revista clinica espanola as English Abstract, Journal Article, with publication-date metadata of 1984 Aug 15-31 (source-text precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-6515072-2006-11-15-4be533a80309`](#source-pubmed-observation-pmid-6515072-2006-11-15-4be533a80309))

### Paragraph 1

PubMed lists PMID 6515072 in Revista clinica espanola as English Abstract, Journal Article, with publication-date metadata of 1984 Aug 15-31 (source-text precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-6515072-2006-11-15-4be533a80309`](#source-pubmed-observation-pmid-6515072-2006-11-15-4be533a80309))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-6515072-2006-11-15-4be533a80309`](#source-pubmed-observation-pmid-6515072-2006-11-15-4be533a80309))

## Sources

<a id="source-pubmed-observation-pmid-6515072-2006-11-15-4be533a80309"></a>
- **\[Possible intervention of glucagon in the genesis of various primary hyperlipemias\]. · retained source version 1:2006-11-15:current:4be533a8030946c2bfb3ffd592948bfd2b81bd1c559ffe7e4e2ff110c6af7c22** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/6515072/) (`pubmed-observation-pmid-6515072-2006-11-15-4be533a80309`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "\[Possible intervention of glucagon in the genesis of various primary hyperlipemias\]." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-6515072-glucagon-v1.json SHA-256: 628588e978fbc437c533638034b1a4cfe9a68171a9ff6916557c16e1ca1b9455.